Published in Transfusion on June 01, 2011
Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility. Asian J Transfus Sci (2015) 0.78
Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients. Transfusion (2010) 1.74
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher (2010) 3.47
Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher (2013) 2.97
Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA (2008) 2.65
The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion (2009) 2.56
A novel mouse model of red blood cell storage and posttransfusion in vivo survival. Transfusion (2009) 2.26
Blood donors and factors impacting the blood donation decision. Transfus Med Rev (2002) 2.25
Noninfectious serious hazards of transfusion. Anesth Analg (2009) 2.21
Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion (2009) 2.04
The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion (2008) 1.77
Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood (2005) 1.77
HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer (2010) 1.63
Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion (2006) 1.62
Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev (2008) 1.61
Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma (2009) 1.56
Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood (2007) 1.55
The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion (2004) 1.43
Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev (2007) 1.40
Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. Transfusion (2012) 1.38
Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher (2007) 1.38
ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci (2010) 1.32
Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol (2002) 1.30
CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion (2003) 1.23
Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr (2011) 1.23
Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants? J Pediatr (2010) 1.10
Transfusion-related acute lung injury: from bedside to bench and back. Blood (2010) 1.08
Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion (2010) 1.04
Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis (2010) 1.03
Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion (2007) 1.01
Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006. Transfusion (2009) 1.01
Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics (2009) 1.01
Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen. Transfusion (2009) 1.00
Racial differences in motivators and barriers to blood donation among blood donors. Arch Pathol Lab Med (2009) 0.99
Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest (2016) 0.97
Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety. Transfusion (2006) 0.96
The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral rates. Transfusion (2010) 0.95
Pathophysiology of early trauma-induced coagulopathy: emerging evidence for hemodilution and coagulation factor depletion. J Trauma (2011) 0.95
Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells. Transfusion (2008) 0.95
2-(Diethylhexyl)phthalate in blood bags: is this a public health issue? Transfusion (2011) 0.94
Early predictors of massive transfusion in patients sustaining torso gunshot wounds in a civilian level I trauma center. J Trauma (2010) 0.93
Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions. Transfus Med Rev (2011) 0.93
Implementation of a pediatric trauma massive transfusion protocol: one institution's experience. Transfusion (2011) 0.92
Blood donation and blood transfusion: special considerations for African Americans. Transfus Med Rev (2008) 0.91
An automatable format for accurate immunohematology testing by flow cytometry. Transfusion (2003) 0.91
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion (2009) 0.91
Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood (2007) 0.90
Transfusion management of trauma patients. Anesth Analg (2009) 0.90
Motivators and barriers to blood donation in African American college students. Transfus Apher Sci (2009) 0.89
Demographic patterns of blood donors and donations in a large metropolitan area. J Natl Med Assoc (2011) 0.88
The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center. Am Surg (2011) 0.88
Outcomes after massive transfusion in nontrauma patients in the era of damage control resuscitation. Am Surg (2012) 0.88
Unappreciated risk factors for transplant patients: HLA antibodies in blood components. Hum Immunol (2004) 0.87
Massive transfusion: blood component ratios. Curr Opin Hematol (2013) 0.87
Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A. Transfusion (2007) 0.87
Blood donations motivators and barriers: a descriptive study of African American and white voters. Transfus Apher Sci (2012) 0.86
Minority donation in the United States: challenges and needs. Curr Opin Hematol (2010) 0.86
Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation. J Immunol (2003) 0.86
Base deficit as a marker of survival after traumatic injury: consistent across changing patient populations and resuscitation paradigms. J Trauma Acute Care Surg (2012) 0.85
Leukoreduction filtration of blood with sickle cell trait. Transfus Med Rev (2004) 0.84
Demographic differences in estimated blood donor eligibility prevalence in the United States. Transfusion (2011) 0.84
Granulocyte transfusion: revisited. Curr Hematol Rep (2003) 0.83
The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apher (2007) 0.83
Contribution of attitudinal factors to blood donation in African American church attendees. Transfusion (2010) 0.83
Improved method for fluorescence cytometric immunohematology testing. Transfusion (2004) 0.82
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion (2014) 0.82
Transfusion-related acute lung injury. Hematol Oncol Clin North Am (2007) 0.82
Development of common metrics for donation attitude, subjective norm, perceived behavioral control, and intention for the blood donation context. Transfusion (2013) 0.82
The blood donor identity survey: a multidimensional measure of blood donor motivations. Transfusion (2014) 0.81
Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion (2013) 0.81
The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine. Transfusion (2014) 0.81
Critical evaluation of informed consent forms for adult and minor aged whole blood donation used by United States blood centers. Transfusion (2009) 0.81
Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia. Am J Hematol (2012) 0.81
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion (2010) 0.80
Effect of mediators of innate immunity and inflammation on CD8+ veto cells. Transplantation (2004) 0.80
Animal models of transfusion-related acute lung injury. Transfus Med Rev (2009) 0.80
Islet transplantation, stem cells, and transfusion medicine. Transfus Med Rev (2003) 0.80
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant (2005) 0.79
Emerging Infections and Blood Safety in the 21st Century. Ann Intern Med (2016) 0.79
Donor lymphocyte infusion therapy. Transfus Med Rev (2002) 0.79
Is there transfusion-related acute renal injury? Anesthesiology (2010) 0.78
Effects of storage duration and volume on the quality of leukoreduced apheresis-derived platelets: implications for pediatric transfusion medicine. Transfusion (2010) 0.78
The value of area-based analyses of donation patterns for recruitment strategies. Transfusion (2014) 0.78
Spotlight on pathogenesis of TRALI: HNA-3a (CTL2) antibodies. Blood (2014) 0.78
Evaluating a program to increase blood donation among racial and ethnic minority communities in New York City. Transfusion (2014) 0.78
Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor. Transfusion (2009) 0.77
Transfusion-transmitted cytomegalovirus: lessons from a murine model. Transfus Med Rev (2007) 0.77
West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic. Transfusion (2012) 0.77
Ex vivo generated red cells as transfusion products. Stem Cells Int (2012) 0.76
Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice. Transfusion (2006) 0.76
Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model. Transfusion (2004) 0.76
Plasma exchange in pancreatitis due to hypertriglyceridemia. Transfusion (2009) 0.75